PMID: 6411321Sep 15, 1983Paper

The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease

Cancer
E WhiteheadC G Beardwell

Abstract

Ovarian function has been studied in 44 adult females who previously received quadruple chemotherapy (MVPP) for Hodgkin's disease. The median age at treatment was 23 years, and the length of time between completion of treatment and study ranged from 6 months to 10 years (median, 30 months). Seventeen women maintained regular menses, 10 developed oligomenorrhea, and 17 developed amenorrhea. At treatment, the 17 women who subsequently developed amenorrhea were significantly older (median, 30 years) than those who maintained regular menses (median, 22 years) or developed oligomenorrhea (median, 23 years). All patients older than 36 years at the start of treatment stopped menstruating during chemotherapy. The cause of the menstrual disturbance in these patients was chemotherapy-induced ovarian damage characterized by high serum gonadotrophin and low serum estradiol concentrations. After completion of treatment there were 17 pregnancies, which resulted in 9 normal infants, 3 terminations, and 4 spontaneous abortions. Nine patients took the combination oral contraceptive pill throughout chemotherapy; however, subsequently 4 developed amenorrhea and 3 oligomenorrhea, suggesting that these patients had not been protected from chemother...Continue Reading

References

Sep 15, 1979·Lancet·E A McKeenM H Zarrabi
Jun 1, 1974·British Journal of Cancer·P C EnglandR A Sellwood
Sep 1, 1980·Cancer Treatment Reviews·S M Shalet
Jun 4, 1981·The New England Journal of Medicine·S J HorningS A Rosenberg
Oct 1, 1981·The American Journal of Medicine·R L SchilskyV T DeVita
Dec 1, 1980·The American Journal of Medicine·J BlattD G Poplack

❮ Previous
Next ❯

Citations

Jan 1, 1987·Journal of Cancer Research and Clinical Oncology·E D KreuserH Heimpel
Mar 1, 1994·Annals of Hematology·C BokemeyerH Poliwoda
Jun 24, 2010·Breast Cancer Research and Treatment·Irit Ben-AharonSalomon M Stemmer
May 23, 2012·Journal of Assisted Reproduction and Genetics·Pascale JadoulUNKNOWN ISFP Practice Committee
Aug 7, 2002·Current Oncology Reports·Simon J Howell, Stephen M Shalet
Feb 1, 1989·Seminars in Oncology Nursing·W L Hobbie, C L Schwartz
May 1, 1993·Reproductive Toxicology·K Ataya, A Ramahi-Ataya
Feb 18, 2004·Fertility and Sterility·Tommaso FalconeJeffery M Goldberg
May 29, 2003·Molecular and Cellular Endocrinology·Satoru SagaeRyuichi Kudo
May 1, 1995·Seminars in Oncology Nursing·M A Lamb
Jan 29, 1999·Endocrinology and Metabolism Clinics of North America·S Howell, S Shalet
Mar 1, 1990·Baillière's Clinical Endocrinology and Metabolism·I D Morris, S M Shalet
Mar 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A B Thomson, W H B Wallace
Jul 27, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A B ThomsonW H B Wallace
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M BowerK D Bagshawe
Jul 10, 2001·Journal of the American College of Surgeons·L W Rice
Feb 1, 2008·Nature Clinical Practice. Oncology·Kazutaka NakayamaNaoto T Ueno
Oct 1, 2008·Human Reproduction Update·Zeev Blumenfeld, Michael von Wolff
Feb 7, 2001·Current Opinion in Obstetrics & Gynecology·J DonnezM Nisolle
Mar 1, 1997·Clinical Obstetrics and Gynecology·K P Jones
Dec 21, 2006·Obstetrical & Gynecological Survey·Enbal Marhhom, Ilan Cohen
Jul 16, 2011·Obstetrical & Gynecological Survey·Roni T FleischerGareth C Weston
Aug 8, 2013·Obstetrical & Gynecological Survey·Sara LangeMichelle Matthews
Jun 1, 1990·International Journal of Andrology·J A TalbotW R Robertson
May 2, 2001·The Journal of Obstetrics and Gynaecology Research·V Sivanesaratnam
Jan 8, 2000·Acta Paediatrica. Supplement·A J Rutherford, R G Gosden
Mar 23, 1985·British Medical Journal·S M ShaletE Whitehead
Feb 1, 1985·Postgraduate Medical Journal·T A Lister
Sep 25, 2007·Blood·Marie L De BruinFlora E van Leeuwen
Jul 19, 2006·Asian Journal of Andrology·Theodoros MaltarisRalf Dittrich
Jan 10, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J PaccouG Damaj
Jun 12, 2013·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Angiolo GadducciIlaria Guiggi
Nov 15, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·T LamlB W Hartmann
Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·Roger G. GosdenAnthony J. Rutherford
Jan 31, 2006·Expert Opinion on Therapeutic Targets·Amanda DuttonPaul G Murray
Jul 16, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Henk R FrankeIstvan Vermes
Jul 14, 2007·Expert Review of Anticancer Therapy·Mohamed F M Mitwally
Jun 10, 2006·Expert Review of Anticancer Therapy·Amanda DuttonPaul G Murray
Jun 1, 1997·Annals of Medicine·Z Blumenfeld, N Haim
Mar 1, 1992·American Journal of Obstetrics and Gynecology·J ByrneJ W Meigs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.